Population‐based study of screening test performance indices of three human papillomavirus DNA tests

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Medical Virology

• Publication date

  2007-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/jmv.20898PMID 17596834
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of Two Commercial Assays for Detection of Human Papillomavirus (HPV) in Cervical Scrape Specimens: Validation of the Roche AMPLICOR HPV Test as a Means To Screen for HPV Genotypes Associated with a Higher Risk of Cervical Disorders

  2005cited by this paper
• Comparison between the Hybrid Capture II Test and a PCR-Based Human Papillomavirus Detection Method for Diagnosis and Posttreatment Follow-Up of Cervical Intraepithelial Neoplasia

  2005cited by this paper
• The role of human papillomavirus testing in cervical screening.

  2005cited by this paper
• Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear.

  2005influential reference
• Epidemiologic classification of human papillomavirus types associated with cervical cancer.

  2003cited by this paper
• Management of women who test positive for high-risk types of human papillomavirus: the HART study.

  2003influential reference
• Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail.

  2002cited by this paper
• Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.

  2002cited by this paper
• Comparisons of HPV DNA detection by MY09/11 PCR methods

  2002influential reference
• Population‐based type‐specific prevalence of high‐risk human papillomavirus infection in middle‐aged Swedish Women

  2002influential reference
• Measuring sensitivity in gynecologic cytology: A review

  2002cited by this paper
• Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia.

  2001cited by this paper
• Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial.

  2001cited by this paper
• Setting the target for a better cervical screening test: characteristics of a cost-effective test for cervical neoplasia screening.

  2001cited by this paper
• A population-based five-year follow-up study of cervical human papillomavirus infection.

  2000cited by this paper
• Setting the Target for a Better Cervical Screening Test: Characteristics of a Cost‐Effective Test for Cervical Neoplasia Screening

  2000cited by this paper
• Human Papillomavirus Testing in Women With Mild Cytologic Atypia

  2000cited by this paper
• Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

  1999influential reference
• Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison.

  1999cited by this paper
• Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study.

  1999cited by this paper
• Natural history of cervicovaginal papillomavirus infection in young women.

  1998cited by this paper
• Natural history of cervicovaginal papillomavirus infection in young women

  1998cited by this paper
• A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings

  1997cited by this paper
• Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

  1995cited by this paper
• Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective

  1995cited by this paper
• The measurement of observer agreement for categorical data.

  1977cited by this paper

• Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV control

  2021cites this paper
• Long-term protection of HPV test in women at risk of cervical cancer

  2020cites this paper
• Knowledge of Human Papillomavirus (HPV), Attitudes and Practices Towards Anti-HPV Vaccination Among Israeli Pediatricians, Gynecologists, and Internal Medicine Doctors: Development and Validation of an Ad Hoc Questionnaire

  2019cites this paper
• Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25–69 years living in Australia

  2018cites this paper
• Long‐term HPV type‐specific risks for ASCUS and LSIL: A 14‐year follow‐up of a randomized primary HPV screening trial

  2015cites this paper
• Human papillomavirus and cervical cancer : detection of potential markers of disease progression using liquid-based cytology.

  2015cites this paper
• Long‐term HPV type‐specific risks of high‐grade cervical intraepithelial lesions: A 14‐year follow‐up of a randomized primary HPV screening trial

  2015influential citation
• Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial

  2014cites this paper
• Comparative effectiveness study on human papillomavirus detection methods used in the cervical cancer screening programme

  2014cites this paper
• Title : 1 A rapid DNA extraction method suitable for Human 2 Papillomavirus ( HPV ) detection 3 4

  2014cites this paper
• A rapid DNA extraction method suitable for human papillomavirus detection

  2014cites this paper
• Cervical cancer screening in Serbia Skrining karcinoma grlia materice u Srbiji

  2013cites this paper
• Cervical cancer screening in Serbia.

  2013cites this paper
• Human Papillomavirus (HPV) DNA Triage of Women with Atypical Squamous Cells of Undetermined Significance with cobas 4800 HPV and Hybrid Capture 2 Tests for Detection of High-Grade Lesions of the Uterine Cervix

  2012cites this paper
• Cytology and Human Papillomavirus Testing 6 to 12 Months after ASCUS or LSIL Cytology in Organized Screening To Predict High-Grade Cervical Neoplasia between Screening Rounds

  2012influential citation
• HPV Testing for Cervical Cancer Screening

  2012cites this paper
• A Simple and Robust Method for Semi-Quantitative Detection of Human Papillomavirus Nucleic Acids (HPV) Helps Oncological Clinicians to Assess the Severeness of HPV Cellular Changing

  2011cites this paper
• Utilidad de las técnicas moleculares de detección de VPH en el control y prevención del cáncer cervicouterino

  2011cites this paper
• Prevention of cervical cancer through use of liquid-based cytology and supplementary HPV testing in population-based screening

  2011cites this paper
• Commercially available assays for multiplex detection of alpha human papillomaviruses

  2010cites this paper
• Human Papillomavirus (HPV) DNA Triage of Women with Atypical Squamous Cells of Undetermined Significance with Amplicor HPV and Hybrid Capture 2 Assays for Detection of High-Grade Lesions of the Uterine Cervix

  2010cites this paper
• Randomised Evaluation of New Technologies within the Population‐Based Cervical Cancer Screening Programme in Finland: Cross‐Sectional Performance and Validity

  2009cites this paper
• A Study of Amplicor Human Papillomavirus DNA Detection in the Atypical Squamous Cells of Undetermined Significance–Low-Grade Squamous Intraepithelial Lesion Triage Study

  2009cites this paper
• Clinical performance of the APTIMA HPV Assay for the detection of high-risk HPV and high-grade cervical lesions.

  2009cites this paper
• Efficiency of the APTIMA HPV Assay for detection of HPV RNA and DNA targets.

  2009cites this paper
• Comparison of human papillomavirus genotyping using commercial assays based on PCR and reverse hybridization methods

  2009cites this paper
• [Cervical cancer screening: restoration or reconstruction?].

  2009cites this paper
• Detection and Typing of Human Papillomavirus Nucleic Acids in Biological Fluids

  2009cites this paper
• Recent Developments in the Dutch Cervical Cancer Screening Programme

  2008cites this paper
• Intégration du test HPV dans le dépistage primaire

  2008cites this paper
• Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

  2008cites this paper
• Human papillomavirus testing and its application in cervical cancer prevention

  2008cites this paper
• [Integrating HPV testing for primary screening?].

  2008cites this paper
• Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma

  2008cites this paper
• Strengthening prevention programs to eliminate cervical cancer in the Nordic countries

  2008cites this paper